295 related articles for article (PubMed ID: 17043241)
1. Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.
Chen S; Xu Y; Yuan X; Bubley GJ; Balk SP
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15969-74. PubMed ID: 17043241
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation.
Chen S; Gulla S; Cai C; Balk SP
J Biol Chem; 2012 Mar; 287(11):8571-83. PubMed ID: 22275373
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients.
Willder JM; Heng SJ; McCall P; Adams CE; Tannahill C; Fyffe G; Seywright M; Horgan PG; Leung HY; Underwood MA; Edwards J
Br J Cancer; 2013 Jan; 108(1):139-48. PubMed ID: 23321516
[TBL] [Abstract][Full Text] [Related]
4. Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancer.
Liu X; Gao Y; Ye H; Gerrin S; Ma F; Wu Y; Zhang T; Russo J; Cai C; Yuan X; Liu J; Chen S; Balk SP
Nucleic Acids Res; 2017 Apr; 45(7):3738-3751. PubMed ID: 28062857
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of the androgen receptor at Ser81 is co-sustained by CDK1 and CDK9 and leads to AR-mediated transactivation in prostate cancer.
Gao X; Liang J; Wang L; Zhang Z; Yuan P; Wang J; Gao Y; Ma F; Calagua C; Ye H; Voznesensky O; Wang S; Wang T; Liu J; Chen S; Liu X
Mol Oncol; 2021 Jul; 15(7):1901-1920. PubMed ID: 33932081
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
Gregory CW; Johnson RT; Presnell SC; Mohler JL; French FS
J Androl; 2001; 22(4):537-48. PubMed ID: 11451350
[TBL] [Abstract][Full Text] [Related]
7. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization.
Gioeli D; Black BE; Gordon V; Spencer A; Kesler CT; Eblen ST; Paschal BM; Weber MJ
Mol Endocrinol; 2006 Mar; 20(3):503-15. PubMed ID: 16282370
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells.
Yuan X; Li T; Wang H; Zhang T; Barua M; Borgesi RA; Bubley GJ; Lu ML; Balk SP
Am J Pathol; 2006 Aug; 169(2):682-96. PubMed ID: 16877366
[TBL] [Abstract][Full Text] [Related]
9. A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells.
Amin KS; Jagadeesh S; Baishya G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
Mol Cancer Ther; 2014 Feb; 13(2):341-52. PubMed ID: 24258347
[TBL] [Abstract][Full Text] [Related]
10. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
[TBL] [Abstract][Full Text] [Related]
12. Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer.
Liu X; Han W; Gulla S; Simon NI; Gao Y; Liu J; Wang L; Yang H; Zhang X; Chen S
Prostate; 2016 May; 76(7):649-61. PubMed ID: 26847655
[TBL] [Abstract][Full Text] [Related]
13. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
Dai JL; Burnstein KL
Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
[TBL] [Abstract][Full Text] [Related]
14. Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor.
Sugita S; Kawashima H; Tanaka T; Kurisu T; Sugimura K; Nakatani T
Oncol Rep; 2004 Jun; 11(6):1273-9. PubMed ID: 15138566
[TBL] [Abstract][Full Text] [Related]
15. Caffeic acid phenethyl ester suppresses the expression of androgen receptor variant 7 via inhibition of CDK1 and AKT.
Kuo YY; Huo C; Li CY; Chuu CP
Cancer Gene Ther; 2024 Jun; 31(6):807-815. PubMed ID: 38480977
[TBL] [Abstract][Full Text] [Related]
16. Cell-cycle-dependent regulation of androgen receptor function.
Koryakina Y; Knudsen KE; Gioeli D
Endocr Relat Cancer; 2015 Apr; 22(2):249-64. PubMed ID: 25691442
[TBL] [Abstract][Full Text] [Related]
17. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
Xu Y; Chen SY; Ross KN; Balk SP
Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382
[TBL] [Abstract][Full Text] [Related]
18. Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.
Ray MR; Wafa LA; Cheng H; Snoek R; Fazli L; Gleave M; Rennie PS
Int J Cancer; 2006 Mar; 118(5):1108-19. PubMed ID: 16161052
[TBL] [Abstract][Full Text] [Related]
19. Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity.
Lyons LS; Burnstein KL
Mol Endocrinol; 2006 May; 20(5):1061-72. PubMed ID: 16384856
[TBL] [Abstract][Full Text] [Related]
20. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
